Infectious and Inflammatory Diseases

Prof. Dor Salomon

Antibacterial treatment

The World Health Organization predicts that by 2050 , multidrugresistant pathogens will become the leading cause of death worldwide . To prevent this catastrophe, the development of novel antibacterial treatments is necessary. Prof. Salomon is employing multidisciplinary approaches to study mechanisms and toxins that are used by https://www.dorsalomonlab.sites.tau.ac.il / bacteria to neutralize their bacterial competitors By adapting and customengineering these natural antibacterial mechanisms, Prof. Salomon is developing nextgeneration antibacterial treatments and prophylactics .

Prof. Salomon, PhD, is at the Department of Clinical Microbiology and Immunology. He completed his PhD (Dean’s direct track) at Tel Aviv University, followed by a Postdoctoral fellowship at the University of Texas Southwestern Medical Center. Prof. Salomon was awarded the NIH Pathway to Independence Award (K99/R00) and was also awarded the Alon Fellowship for young investigators and the prestigious European Research Council (ERC) starting grant. During the period of COVID -19 quarantine, he organized a virtual international conference with over 400 participants, named T6SympoZOOM.